WallStreetZenWallStreetZen

AnalystsKonstantinos N. Aprilakis
Konstantinos N. Aprilakis's Stock Forecasts

Analyst Ranking
Bottom 11%
#4070 out of 4529 analysts
Average Return
-14.83%
Win Rate
36%4 out of 11
Risk vs Reward
Poor
Good

Konstantinos N. Aprilakis's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Blueprint Medicines CorpBPMC
+82.07%$57.77$105.18
2020-03-16 -
2021-03-17
Strong Buy
Loxo Oncology IncLOXO
+47.51%$159.08$234.66
2018-11-12 -
2019-02-15
Buy
Loxo Oncology IncLOXO
+27.65%$183.83$234.66
2018-06-03 -
2019-02-15
Buy
Blueprint Medicines CorpBPMC
+2.40%$76.67$78.51
2018-06-03 -
2019-06-04
Buy

Konstantinos N. Aprilakis Analyst Color

Get additional color on Konstantinos N. Aprilakis's coverage of popular stocks

Konstantinos N. Aprilakis's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Sutro Biopharma IncSTRO
2Strong Buy$25.00N/AInitiates Coverage On
3 years ago
Syndax Pharmaceuticals IncSNDX
1Strong Buy$32.00N/AInitiates Coverage On
3 years ago
Mersana Therapeutics IncMRSN
1Strong Buy$33.00N/AInitiates Coverage On
3 years ago
Kura Oncology IncKURA
1Strong Buy$45.00N/AInitiates Coverage On
3 years ago
Deciphera Pharmaceuticals IncDCPH
1Strong Buy$75.00N/AInitiates Coverage On
3 years ago
Blueprint Medicines CorpBPMC
3Hold$110.00N/AInitiates Coverage On
3 years ago
Adc Therapeutics SaADCT
1Hold$42.00N/AInitiates Coverage On
3 years ago
Loxo Oncology IncLOXO
2Buy$215.00N/AMaintains
5 years ago
Anaptysbio IncANAB
1Buy$153.00N/AMaintains
6 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.